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The HIRA chaperone complex, comprised of HIRA,
UBN1, and CABIN1, collaborates with histone-bind-
ing protein ASF1a to incorporate histone variant
H3.3 into chromatin in a DNA replication-indepen-
dent manner. To better understand HIRA’s function
and mechanism, we integrated HIRA, UBN1,
ASF1a, and histone H3.3 chromatin immunoprecipi-
tation sequencing and gene expression analyses.
Most HIRA-binding sites colocalize with UBN1,
ASF1a, and H3.3 at active promoters and active
and weak/poised enhancers. At promoters, binding
of HIRA/UBN1/ASF1a correlates with the level of
gene expression. HIRA is required for deposition of
histone H3.3 at its binding sites. There are marked
differences in nucleosome and coregulator composi-
tion at different classes of HIRA-bound regulatory
sites. Underscoring this, we report physical interac-
tions between the HIRA complex and transcription
factors, a chromatin insulator and an ATP-dependent
chromatin-remodeling complex. Our results map the
distribution of the HIRA chaperone across the chro-
matin landscape and point to different interacting
partners at functionally distinct regulatory sites.INTRODUCTION
The HIRA chaperone complex, comprised of HIRA, UBN1, and
CABIN1, collaborates with histone-binding protein ASF1a to
incorporate the histone variant H3.3 into chromatin in a DNA
replication-independent manner (Loppin et al., 2005; Ray-Gallet
et al., 2002; Tagami et al., 2004). HIRA is required for early em-
bryo development (Roberts et al., 2002; Szenker et al., 2012),
and histone H3.3 is mutated in human cancer (Schwartzentruber
et al., 2012; Wu et al., 2012).
Histone H3.3 is enriched at nucleosomes at transcription start
sites (TSSs) of genes, at enhancers, and gene bodies of actively
transcribed genes (Ahmad and Henikoff, 2002; Goldberg et al.,
2010; Jin et al., 2009). Histone H3.3 contributes to nucleosome
destabilization (Jin and Felsenfeld, 2007) and so is thought to
facilitate nucleosome dynamics associated with transcription1012 Cell Reports 3, 1012–1019, April 25, 2013 ª2013 The Authorsactivation and ongoing transcription. The HIRA protein is
required for deposition of histone H3.3 at many of these regions
(Goldberg et al., 2010; Ray-Gallet et al., 2011). Consistent with
this, HIRA is required for gene activation in some contexts (Dutta
et al., 2010; Placek et al., 2009; Yang et al., 2011). Interestingly,
the HIRA complex and its orthologs, together with histone H3.3,
are also involved in chromatin silencing (Sherwood et al., 1993;
van der Heijden et al., 2007).
The distribution of the HIRA chaperone complex across the
epigenome is not known, and there is a paucity of partner pro-
teins known to participate in its diverse functions. To overcome
this, we performed integrated chromatin immunoprecipitation
sequencing (ChIP-seq) and gene expression analyses and
used these analyses to identify proteins that physically interact
with the HIRA complex in chromatin regulation.RESULTS
Analysis of Genome-wide Distribution of HIRA, UBN1,
ASF1a, and Histone H3.3
To gain insight into the function and regulation of the HIRA
chaperone at distinct genomic sites, we performed ChIP-seq
of endogenous HIRA, UBN1, and ASF1a in human HeLa cells.
Analysis of the aligned reads yielded 8,296 HIRA peaks,
62,712 UBN1 peaks, and 64,550 ASF1a peaks, compared to
input DNA. Of HIRA peaks, 74% (6,147 out of 8,296) were co-
occupied by both UBN1 and ASF1a (Figure 1A; Table S1). To
confirm these results, we performed anti-HIRA ChIP followed
by quantitative PCR (ChIP-qPCR) at a single co-occupied
HIRA/UBN1/ASF1a peak and flanking regions. This analysis
confirmed enrichment of HIRA at the peak, relative to the flanking
regions (Figure 1B). Specific enrichment at this site was also
observed with antibodies to UBN1 and ASF1a (Figure 1C) as
well as with four individual monoclonal antibodies to HIRA (Fig-
ure S1A) by ChIP-qPCR. Indeed, across the whole genome,
HIRA-binding regions were coincident with UBN1 and ASF1a-
binding regions (Figure 1D). We also performed ChIP of HIRA
followed by semi-qPCR at nine distinct locations selected at
random from the list of 6,147 HIRA/UBN1/ASF1a peaks; all
nine regions demonstrated enrichment in HIRA ChIP compared
to nonspecific antibody (anti-GFP) (Figure 1E; Table S2). Taken
together, these data show that the core HIRA complex and
ASF1a co-occupy at least several thousand discrete sites across
the genome of proliferating human cells.
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Figure 1. ChIP-Seq of HIRA, UBN1, and ASF1a Defines HIRA Complex and ASF1a-Binding Sites
(A) Venn diagram of overlap between HIRA, UBN1 and ASF1a peaks reveals a subset of 6,147 co-occupied regions. See also Table S1.
(B) Representative HIRA, UBN1, ASF1a, and HA-H3.3 ChIP-seq tracks andChIP-qPCR validation of HIRA enrichment at peak compared to flanking regions. Error
bars show SEs. See also Table S2.
(C) ChIP-qPCR validation of the complex-binding region shown in (B) using a cocktail of monoclonal antibodies to HIRA or ASF1a or a rabbit polyclonal antibody
to UBN1. Error bars show SEs. neg., negative. See also Figure S1A and Table S2.
(D) Normalized density of ChIP-seq tags of HIRA, UBN1, and ASF1a in a 4 kb window centered on a composite of all HIRA peaks.
(E) ChIP-PCR validation of nine different HIRA-binding regions identified by ChIP-seq. See also Table S2.
(F) Normalized density of ChIP-seq tags of HA-H3.3 in a 4 kb window centered on a composite of all HIRA/UBN1/ASF1a peaks.Although HIRA is required for accumulation of histone H3.3
at many sites throughout the genome (Dutta et al., 2010; Gold-
berg et al., 2010; Placek et al., 2009; Yang et al., 2011), the
genomic distribution of newly deposited histone H3.3 and the
HIRA complex (as well as ASF1a) have not been directly
compared. Therefore, we assessed the genome-wide distribu-
tion of the newly incorporated histone H3.3 by anti-HA ChIP-Cseq on HeLa cells after a short pulse of HA-histone H3.3 expres-
sion (less than 13 hr). By this approach, we identified 110,213
sites of HA-H3.3 deposition across the genome. Strikingly,
86% of all HIRA-binding sites and 95% of co-occupied
HIRA/UBN1/ASF1a sites were also enriched for HA-H3.3. More-
over, across the whole genome, co-occupied HIRA/UBN1/
ASF1a sites were generally coincident with peaks of HA-H3.3ell Reports 3, 1012–1019, April 25, 2013 ª2013 The Authors 1013
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Figure 2. HIRA Binds to Chromatin at Four
Distinct Classes of Genomic Loci
(A) Unsupervised clustering identifies four distinct
clusters of HIRA peaks.
(B) Heatmaps of normalized density of ChIP-seq
tags of HA-H3.3, H2Az, and FAIRE in a 10 kb
window centered on a HIRA peak. HIRA peaks are
arranged in the same order as in (A) and grouped in
four clusters. See also Figure S1.
(C) siRNA-mediated knockdown of HIRA impairs
HA-H3.3 incorporation at representative regions of
clusters 1, 2, and 3 as measured by HA ChIP-
qPCR. Error bars show SEs. CTRL, control. See
also Figure S2A for confirmation of efficient protein
knockdown and Table S2 for regions location.deposition (Figures 1B and 1F). Furthermore, peaks of histone
H3.3 were more pronounced at peaks of HIRA/UBN1/ASF1a
than elsewhere in the genome (Figure S1B). These results sup-
port the view that the HIRA complex and ASF1a collaborate to
deposit histone H3.3 at their specific colocalization sites.
HIRA Binds to Chromatin at Four Distinct Classes of
Genomic Loci
To further characterize chaperone function, we determined
the distribution of regions co-occupied by HIRA, UBN1, and
ASF1a between promoter, genic and intergenic regions: 22%
of the 6,147 HIRA/UBN1/ASF1a peaks mapped to gene pro-
moters and the rest to either gene body (38%) or intergenic re-
gions (40%) (Figures S1C and S1D).
To better characterize HIRA’s binding across the genome, we
performed unsupervised clustering of all 8,296 HIRA-binding
sites according to their overlap with UBN1, ASF1a, HA-H3.3,
and other chromatin proteins and genomic features annotated1014 Cell Reports 3, 1012–1019, April 25, 2013 ª2013 The Authorsin HeLa cells in publicly available data-
bases. In addition, we performed formal-
dehyde-assisted isolation of regulatory
elements (FAIRE) to identify accessible
regions of DNA in the same cells and
incorporated this into the analysis (Table
S1). This analysis separatedHIRA-binding
sites into four distinct clusters: 1, 2, 3, and
4 (Figure 2A). Clusters 1–3 were com-
prised largely of HIRA peaks co-occupied
by UBN1 and ASF1a, whereas cluster 4
was predominantly comprised of HIRA-
only peaks, lacking UBN1 and ASF1a.
Cluster 1 is enriched in H3K4me1/
H3K4me3, H3K27ac, H2Az, p300, and
transcription factor c-MYC (Figure 2A).
Almost all regions in this cluster are also
FAIRE positive and DNase hypersensitive
(DNaseHS) and exhibit very low overlap
with RNA polymerase II, CpG islands, or
promoters of annotated genes. Such a
binding pattern is best associated with
active enhancers (Ernst et al., 2011;
Heintzman et al., 2009; Rada-Iglesiaset al., 2011), suggesting that cluster 1 represents HIRA/UBN1/
ASF1a binding at these regulatory elements.
Cluster 2 shows a strong overlap with gene promoters,
RNA polymerase II, CpG islands, H2Az, H3K4me3 (but not
H3K4me1), H3K27ac, and transcription factor c-MYC (Fig-
ure 2A). Almost all regions in this cluster are FAIRE positive
and DNaseHS. This signature is most consistent with promoters
of actively transcribed genes (Ernst et al., 2011; Heintzman et al.,
2009; Rada-Iglesias et al., 2011).
Cluster 3 is enriched in H3K4me1, but compared to cluster 1,
shows less overlap with p300, H3K27ac, and c-MYC and less
DNaseHS and FAIRE (Figure 2A). Moreover, cluster 3 shows
minimal overlap with promoters, CpG islands, and RNA poly-
merase II. Consequently, cluster 3 is most consistent with
weak or poised enhancers (Ernst et al., 2011; Heintzman et al.,
2009; Rada-Iglesias et al., 2011).
Cluster 4 is comprised largely of the 1,008 genomic sites that
bind HIRA, but neither UBN1 nor ASF1a (HIRA-only peaks)
(Figures 1A and 2A). Relaxing the stringency of the algorithm for
calling ASF1a and UBN1 peaks failed to generate overlap
between UBN1 and ASF1a peaks and all the HIRA peaks
(Figure S1E). Also, independent reanalysis of read numbers
confirmed that those HIRA peaks that scored negative for both
ASF1a and UBN1 showed only very few reads in UBN1 and
ASF1a ChIPs at these regions (Figure S1F). These analyses sup-
port the notion that these apparent HIRA-only peaks genuinely
lack enrichment of UBN1 and ASF1a and so are qualitatively
distinct from the co-occupied HIRA/UBN1/ASF1a peaks. Con-
sistent with this idea, unlike the HIRA/UBN1/ASF1a-bound re-
gions of the genome, HIRA-only peaks were largely FAIRE and
DNaseHS negative, lacked active histone marks (H3K4me3,
H3K27ac, and H3K9/14ac) (Figures 2A and S1G), and overlap-
ped poorly with many chromatin regulatory proteins analyzed
as part of the ENCODE project (Figure S1H; Table S3). Based
on the analysis in Figure 2A, a large proportion of cluster 4
HIRA-binding sites contains detectable H2Az, but a more quan-
titative analysis, evaluating the number of reads and not simply
the presence or absence of binding, showed these sites to be
very poor binders of H2Az (Figure 2B). Most surprisingly, in strik-
ing contrast to HIRA/UBN1/ASF1a peaks, the HIRA-only sites
were also largely depleted of histone H3.3 (Figures 2A, S1G,
and S1I). Taken together, these data suggest that HIRA binds
to some sites in the genome in the absence of UBN1 and
ASF1a and without steady-state enrichment of histone H3.3.
Together, this indicates a very different, but currently unknown,
function for HIRA at these sites.
To gain further insight into HIRA clusters 1–4 we also plotted
quantitative heatmaps of the abundance of newly synthesized
HA-histone H3.3, H2Az, and FAIRE accessibility, 5 kb either
side of the centered HIRA peak, and with the HIRA-binding loci
vertically ordered as in Figures 2A and 2B. These plots under-
scored the difference between clusters 1–4. At cluster 2, as
expected for promoters, HA-H3.3 and H2Az both showed a
bimodal distribution, indicative of H3.3/H2Az-containing nucleo-
somes either side of the nucleosome-free, FAIRE-positive TSS
(Jin et al., 2009). Interestingly, the nucleosome-free region was
positioned very close to the centered HIRA peak (Figure 2B).
Thus, at promoters, HIRA/UBN1/ASF1a is essentially localized
to the nucleosome-free TSS. Although the active enhancers in
cluster 1 were also characterized by coincident HIRA/UBN1/
ASF1a and FAIRE peaks, the distribution of HA-H3.3 and H2Az
was quite different from the promoters in cluster 2 (Figure 2B).
Cluster 1 HIRA/UBN1/ASF1a peaks were less rich in H2Az,
and the bimodal distribution of HA-H3.3 and H2Az was less
apparent. The weak/poised enhancers of cluster 3 were also
characterized by coincident HIRA/UBN1/ASF1a, FAIRE, and
HA-H3.3 peaks (Figure 2B). As at cluster 1, the HA-H3.3 was
localized to a monomodal, not bimodal, peak. There was rela-
tively little H2Az at cluster 3.
Knockdown of HIRA decreased total incorporation of histone
H3.3 into chromatin, as judged by total chromatin-bound (insol-
uble in Triton X-100) histone H3.3 and total DNA coprecipitated
in anti-HA-H3.3 ChIP (Figures S2A and S2B). At specific regions,
knockdown of HIRA specifically blocked binding of ectopically
expressed epitope-tagged H3.3 at TSSs and promoters (cluster
2) (Figures 2C and S2B), with a much lesser effect on totalCendogenous H3 (H3.1, H3.2, and H3.3) at the same sites (Fig-
ure S2B). Similarly, loss of HIRA resulted in greatly reduced
incorporation of histone H3.3 at cluster 1 and 3 enhancer regions
(Figure 2C).
These results indicate that the HIRA complex and ASF1a
colocalize with histone H3.3 at diverse regulatory elements
throughout the genome (active promoters, strong enhancers,
and weak/poised enhancers) and are required for deposition of
H3.3 at these sites. Significantly, the localization of histone
H3.3 and H2Az differs quantitatively and qualitatively between
these different classes of HIRA/UBN1/ASF1a-bound regulatory
elements.
Binding of HIRA/UBN1/ASF1a at TSSs Correlates with
Gene Expression
The previous comparison of HIRA binding to nucleosome
composition and positioning (Figure 2B) suggested that cluster
2 is comprised of HIRA/UBN1/ASF1a bound to gene promoter
TSSs. Indeed, when HIRA, UBN1, and ASF1a binding was
analyzed at a composite of all genes, the three components
were found to bind just upstream of the TSS, coincident with
the FAIRE-positive nucleosome-free region between the H3.3/
H2Az nucleosomes (Figures 3A and 3B). The composite plot in
Figure 3A reflects the average distribution at individual genes
(Figure 3C). Significantly, the complex was markedly enriched
at the promoters of highly expressed genes but almost absent
from the promoters of repressed genes (Figure 3D), demon-
strating a positive correlation between HIRA/UBN1/ASF1a bind-
ing and gene expression level. In this respect, HIRA/UBN1/
ASF1a binding was very similar to H3.3, H2Az, and FAIRE acces-
sibility (Figure 3E). Taken together, these results show that a
proportion of the HIRA/UBN1/ASF1a complex is localized to
TSSs of highly expressed genes.
Binding Partners of HIRA Complex and ASF1a
Figure 2A reveals a marked overlap between HIRA/UBN1/
ASF1a-binding sites and binding of transcription factors and
transcription regulators. Strikingly, 76% of HIRA/UBN1/ASF1a
peaks colocalize with at least one protein from four families:
human SWI/SNF ATP-dependent chromatin-remodeling com-
plexes (BRG1, INI1, BAF155, and BAF170); AP-1 (c-FOS,
c-JUN, and JUND [clusters 1 and 3]); c-MYC/MAX (clusters 1
and 2); and TFAP2 (TFAP2A and TFAP2C [clusters 1 and 2]) (Fig-
ures 2A and 4A; Table S3). The most robust overlap was
observed with various members of the SWI/SNF family of chro-
matin remodelers. Specifically, 57%, 41%, 41%, and 36% of
HIRA/UBN1/ASF1a peaks overlapped with BAF155, BAF170,
INI1, and BRG1, respectively (Table S3). This overlap was partic-
ularly marked at active enhancers and promoters (clusters 1 and
2, respectively) (Figure 2A). These transcription regulators repre-
sent candidate HIRA/UBN1/ASF1a-bound regulatory partners.
To confirm whether these candidates for HIRA/UBN1/ASF1a-
binding partners identified by ChIP-seq are bona fide interacting
proteins, we tested specific interactions by immunoprecipita-
tion-western blot analysis. Transcription factors c-MYC,
c-JUN, GTF2I (a multifunctional promoter-binding transcription
factor; Roy, 2012), chromatin remodelers of the SWI/SNF family
(BRG1, BRM, and INI1), and chromatin insulator CTCF (enrichedell Reports 3, 1012–1019, April 25, 2013 ª2013 The Authors 1015
A C
2012-09-24 (2)
-5kb +5kbTSS
ASF1a
-5kb +5kbTSS
HIRA
-5kb +5kbTSS
UBN1
-5kb +5kbTSS
H3.3
-5kb +5kbTSS
FAIRE
-5kb +5kbTSS
H2Az
ex
pr
es
si
on
 le
ve
l
2012-09-24 (2)
N
or
m
al
iz
ed
 ta
g 
co
un
t
Distance to TSS, kb. 
N
or
m
al
iz
ed
 ta
g 
co
un
t
E
0.00
0.02
0.04
0.06
0.08
0.10
0.12
 -4
.5
 k
b
 -2
.5
 k
b
 -0
.5
 k
b
7.
5%
17
.5
%
27
.5
%
37
.5
%
47
.5
%
57
.5
%
67
.5
%
77
.5
%
87
.5
%
97
.5
%
 +
1.
5 
kb
 +
3.
5 
kb
High expression
Medium expression
Low expression
H
IR
A
/U
B
N
1/
A
SF
1a
 
pe
ak
  f
re
qu
en
cy
 
composite gene SETSST
Distance to TSS, kb. 
D
0.000
0.001
0.001
0.002
0.002
-2 -1 0 1 2
H3.3
H2Az
FAIRE
0.000
0.001
0.001
0.002
0.002
-2 -1 0 1 2
HIRA
UBN1
ASF1a
B
Figure 3. HIRA Complex and ASF1a Are Enriched at the Nucleosome-free Region of TSSs of Highly Expressed Genes
(A) Normalized density of ChIP-seq tags of HIRA, UBN1, and ASF1a in a 4 kb window of a composite promoter centered on TSSs of all genes.
(B) Normalized density of ChIP-seq tags of H3.3, H2Az, and FAIRE in a 4 kb window of a composite promoter centered on TSS of all genes.
(C) Example of characteristic distribution of HIRA, UBN1, and ASF1a across the DYNLRB1 gene. chr20, chromosome 20.
(D) Composite distribution of co-occupied HIRA/UBN1/ASF1a peaks across high-, medium-, or low-expressed genes. Probes on the Affymetrix expression array
were rank ordered by average expression level in proliferating HeLa cells. Probes were mapped to Ensembl genes and the top (high)-, bottom (low)-, and middle
(medium)-expressed 2,000 genes selected. HIRA/UBN1/ASF1a peak frequency across a composite gene assembled from each group of 2,000 genes was
plotted. The x axis shows the position along the gene, where the distance between TSSs and transcription end sites (TESs) is in percentage (%) of gene length,
and regions upstream of TSSs and downstream of TESs are in base pairs.
(E) Heatmaps of normalized density of ChIP-seq tags of HIRA, UBN1, ASF1a, H3.3, H2Az, and FAIRE in a 10 kb window centered on TSSs. TSSs are rank ordered
according to the expression level of the corresponding transcript.in clusters 1 and 2; Figure 2A) were all specifically coprecipitated
with endogenous HIRA from HeLa lysates, whereas an abun-
dant chromatin-binding protein MCM2 and transcription factor1016 Cell Reports 3, 1012–1019, April 25, 2013 ª2013 The AuthorsTCF4 were not (Figure 4B). The interaction between HIRA and
BRG1 was additionally confirmed using ectopically expressed
epitope-tagged proteins (Figure 4C).
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Figure 4. Genomic Overlap and Functional
Interaction between HIRA/UBN1/ASF1a
and BRG1/INI1
(A) Overlap between HIRA/UBN1/ASF1a peaks
and various proteins studied under the ENCODE
project. See also Table S3.
(B) Immunoprecipitation (IP) of endogenous
HIRA from nuclear lysates coprecipitates other
members of the chaperone complex (UBN1,
ASF1a) as well as transcription factors (c-JUN,
c-MYC, GTF2i), members of SWI/SNF chromatin
remodelers (BRG1, BRM, INI1), and CTCF, but not
TCF4 or MCM2. See also Figure S3.
(C) Coprecipitation of ectopically expressed
epitope-tagged HA-HIRA and FLAG-BRG1.
(D) Coprecipitation of endogenous members of
UBN1, ASF1a, CABIN1, and SWI/SNF complex
(BRG1/INI1) from nuclear lysates.
(E) HIRA/UBN1/ASF1a colocalizes with BRG1 and
INI1 at the TSS of highly expressed genes. Distri-
bution of genic BRG1, BRG1-positive HIRA/
UBN1/ASF1a, INI1, and INI1-positive HIRA/UBN1/
ASF1a peaks plotted against the normalized gene
coordinate (x axis), with genes sorted according to
their level of expression in HeLa cells. Gray win-
dows show at least 2-fold enrichment of HIRA/
UBN1/ASF1a relative to input.Antibodies to UBN1 and ASF1a also coprecipitated subunits
of SWI/SNF, BRG1, and INI1 (Figure 4D). Conversely, antibodies
to BRG1 and INI1 coprecipitated HIRA, UBN1a, ASF1a, and
CABIN1 (Figure 4D). Confirming appropriate specificity and
sensitivity of these assays, only antibodies to ASF1a coprecipi-
tatedMCM2 (Figure 4D). The DNA replication-independent chro-
matin regulators HIRA, UBN1, INI1, and BRG1 do not interact
with the DNA replication helicase MCM2, whereas ASF1a does
bind to MCM2 due to its HIRA/UBN1/CABIN1-independent
role in DNA replication-coupled nucleosome assembly (Groth
et al., 2007). Coprecipitation of HIRA, BRG1, and INI1 was
largely resistant to denaturation of DNA-protein interactions by
ethidium bromide in the lysis buffer and occurred even after
digestion of chromatin to predominantly mono- and dinucleo-
somes (Figure S3A), suggesting that the coprecipitation does
not reflect an indirect interaction mediated by long-range chro-
matin structure.
To verify close physical proximity between HIRA and the
BRG1/INI1 complex, we used the proximity ligation assayCell Reports 3, 1012–101(PLA), an epifluorescence-based method
that scores physical close proximity of
target proteins at the molecular level (Fre-
driksson et al., 2002). Using in situ PLA
under stringent conditions designed to
remove proteins not stably bound to
chromatin, we demonstrated that HIRA
is located in close proximity to BRG1
and INI1 (Figures S3B and S3C). This
assessment of proximity was specific,
by reference to cells in which HIRA was
knocked down by shRNA and antibodiesto several proteins not known to interact with HIRA (DNMT1,
MCM2, UACA, ATRX, XRN1, MBD2, LSH, and EDC4; Figures
S3B and S3C). In sum, targeted immunoprecipitation-western
blot analyses and PLAs verifiedmany of the physical interactions
indicated by ChIP-seq. Of particular note, BRG1/INI1 appears to
physically interact, directly or indirectly, with multiple members
of the HIRA complex and ASF1a.
To further investigate the HIRA/UBN1/ASF1a and BRG1/INI1
interaction, we more closely compared the genome-wide distri-
bution of co-occupied HIRA/UBN1/ASF1a-binding sites with
previously published data describing the genome-wide distribu-
tion of BRG1 and INI1, also in HeLa cells (Euskirchen et al., 2011).
This analysis revealed coincident HIRA/UBN1/ASF1a and BRG1
peaks, overlapping with H3.3-containing nucleosomes (e.g.,
Figure S3D). Like HIRA/UBN1/ASF1a, BRG1/INI1 has been
previously reported to be enriched at many gene TSSs, and un-
supervised clustering revealed marked overlap of HIRA/UBN1/
ASF1a and BRG1/INI1 at active gene promoters (cluster 2,
Figure 2A). Indeed, at genic regions, colocalization between9, April 25, 2013 ª2013 The Authors 1017
HIRA/UBN1/ASF1a and BRG1/INI1 was most prominent at the
TSS of highly expressed genes (Figure 4E).
DISCUSSION
More than 6,000 loci are co-occupied by HIRA, UBN1, and
ASF1a across the genome. We also find a striking colocalization
with histone H3.3, its preferred deposition substrate, at 95%
(5,867) of these sites. HIRA contributes to total deposition of his-
tone H3.3 in the genome and at all its specific binding sites
tested. Co-occupied HIRA, UBN1, and ASF1a-binding sites
occur at three main regulatory elements; namely, promoters of
active genes and active and weak/poised enhancers. At active
promoters, histone H3.3 andH2Az both show a bimodal distribu-
tion reflecting H3.3/H2Az-containing nucleosomes either side of
the TSS. However, active and weak/poised enhancers exhibit
monomodal H3.3 and H2Az peaks. Active enhancers bind
more H3.3 andH2Az thanweak/poised enhancers. These results
extend previous studies to further distinguish between different
local nucleosome structures at distinct regulatory elements
(Ernst et al., 2011; Heintzman et al., 2009; Rada-Iglesias et al.,
2011).
At gene promoters, HIRA, UBN1, and ASF1a bind at the
FAIRE-positive ‘‘nucleosome-free’’ region just upstream of the
TSS, and binding of all three factors, as well as H2Az and H3.3
either side of the TSS, shows a striking correlation with gene
expression. The nucleosome-free region is thought to dynami-
cally cycle between the nucleosome-bound and unbound state
(Jin et al., 2009). The chaperone complex likely contributes to
these dynamics. Interestingly, whereas histone H3.3 accumu-
lates at the 30 end of gene bodies of actively transcribed genes
(Goldberg et al., 2010), we did not observe enrichment of
HIRA/UBN1/ASF1a at these regions (Figures 3C and 3D). This
suggests that HIRA/UBN1/ASF1a is more stably bound to
TSSs, where there is perhaps a more long-term requirement in
anticipation of transcription initiation, compared to gene bodies
where it is only transiently required in conjunction with transcrip-
tion-coupled nucleosome reassembly.
Surprisingly, HIRA binds to at least 1,000 sites across the
genome, in the absence of UBN1 and ASF1a (HIRA-only-binding
sites). The chromatin landscape of these HIRA-only sites is very
different from combined HIRA/UBN1/ASF1a-binding sites. Most
notably, HIRA-only-binding sites are not enriched in H3.3, sug-
gesting a quite different function for HIRA in the absence of
UBN1 and ASF1a. To date, these 1,000 HIRA-only-binding sites
have not revealed other features in common, so the nature of this
function is currently unknown.
We identified proteins that bind directly or indirectly to ASF1a
and/or the HIRA complex, namely c-JUN, c-MYC, GTF2I, CTCF,
and BRG1/INI1. Their interaction with the H3.3 chaperone is
likely to direct and modulate histone chaperone activity. A phys-
ical interaction between the HIRA complex and ASF1a and
BRG1 and INI1 is consistent with previous reports that have
linked members of the HIRA complex and SWI/SNF ATP-depen-
dent chromatin-remodeling factors in model organisms (Dimova
et al., 1999; Konev et al., 2007; Moshkin et al., 2002). Our ChIP-
seq analysis indicates that the HIRA/UBN1/ASF1a interaction
with BRG1/INI1 likely occurs preferentially at active promoters1018 Cell Reports 3, 1012–1019, April 25, 2013 ª2013 The Authorsand enhancers, compared to weak/poised enhancers. This illus-
trates a general conclusion of our analysis that the nucleosome
and coregulator composition of the chaperone’s binding sites
varies considerably between the different types of regulatory
elements. Presumably, different networks of physical and func-
tional interactions, involving HIRA/UBN1/ASF1a, dictate the
distinct functional properties of active promoters and active
and weak/poised enhancers.
EXPERIMENTAL PROCEDURES
See Extended Experimental Procedures for more details and references.
HIRA, UBN1, and AFS1a ChIP
HeLa cells were crosslinked with 1.5 mM EGS in PBS for 45 min at room tem-
perature, followed by treatment with 1% formaldehyde for 15 min. After
quenching with glycine, the cells were harvested and sonicated to produce
soluble chromatin with DNA fragments in the range of 150–300 bp. For
ChIP, this fragmented chromatin was incubated with antibodies to HIRA,
UBN1, or ASF1a preimmobilized on Dynabeads.
Histone ChIP
HeLa cells were crosslinked with 1% formaldehyde in DMEM for 15 min. After
that, the procedure was similar to HIRA ChIP.
FAIRE
FAIRE DNA was purified from the same inputs that were used for HA-H3.3
ChIPs as described previously by Giresi et al. (2007). Briefly, input sample
was extracted twice with phenol-chloroform-isoamyl alcohol mixture, and
FAIRE DNA was recovered from the aqueous phase using QIAGEN PCR
clean-up kit.
Massively Parallel Sequencing and Data analysis
Libraries were prepared from 10 to 20 ng of ChIP or input DNA using Illumina
ChIP-seq kit according to the manufacturer’s instructions, and the resulting
libraries were sequenced on GAIIx to yield about 30 million raw reads. ChIP-
seq or input readsweremapped to the human genome (hg18) using the Bowtie
alignment software. Only unique reads mapping to a single location were re-
tained. Determination of enriched regions was performed using the USeq
package, and reads were visualized using the UCSC browser. Results pre-
sented are analyzed from a single ChIP-seq reaction of each of UBN1 and
ASF1a, but results are representative of two independent ChIP-seq reactions
for HIRA.
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